Clinical trial Recruiting at 1 site Observational Ages 18 and up

Testing the STUMBL chest-injury risk score

Official title: Validation of the STUMBL Score for Risk Stratification in Emergency Department Patients With Blunt Thoracic Trauma: A Prospective Observational Study in Iraq

Run by Al-Nahrain University · NCT06734338 · Data updated 2026-11-12

This project will test whether the STUMBL score can predict serious outcomes for adults who arrive at the emergency department with blunt chest injuries in Baghdad.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment188 (estimated)
SponsorAl-Nahrain University
Academic / other
Drugs / interventionsradiation
Locations1 site (Baghdad)
StatusRecruiting
StartedApril 20, 2025
Main results expectedDecember 10, 2026
Study endsDecember 20, 2026
Registry record updatedMarch 4, 2026
Trial IDNCT06734338 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18 years and older) who present within 4 hours of blunt thoracic trauma to the Al‑Nahrain University emergency department and can provide informed consent (or have a legal guardian consent) are the ideal candidates.

Probably not a fit

Pregnant women, children under 18, patients with penetrating chest trauma, those with other life‑threatening injuries that overshadow the chest injury, or people with prior major thoracic surgery are excluded and likely will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational study enrolling adults with blunt thoracic trauma presenting to the emergency department at Al‑Nahrain University in Baghdad. Clinicians will calculate the STUMBL score on arrival using age, number of rib fractures, chronic lung disease, anticoagulant use, and oxygen saturation, and patients will be followed for outcomes such as mortality, ICU admission, and need for advanced interventions. Demographic and clinical data including injury mechanism, comorbidities, and length of stay will be collected to examine factors that modify score performance. The study aims to measure the score's predictive accuracy and risk-stratification utility in a resource-limited setting.

Why it matters

Potential benefit: If successful, the STUMBL score could help clinicians quickly identify which chest-injury patients need higher-level care and reduce missed severe injuries in a resource-limited ED.

How similar studies have gone: Previous validations in higher-resource settings have shown the STUMBL score can predict complications after blunt chest wall trauma, but it has limited external validation in resource-limited settings like Iraq.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting to the emergency department with blunt thoracic trauma (e.g., motor vehicle accidents, falls, or direct impacts to the chest).
* Patients who present within 4 hours of sustaining the injury.
* Patients or their legal guardians must provide informed consent to participate in the study.

Exclusion Criteria:

* Patients with penetrating chest trauma (e.g., stab wounds, gunshot wounds).
* Patients with other life-threatening injuries that overshadow the thoracic trauma (e.g., head or abdominal trauma).
* Pregnant women due to potential risks related to radiation or certain diagnostic procedures.
* Pediatric patients under 18 years of age.
* Patients with a history of major thoracic surgery (e.g., prior lung or heart surgery) that may interfere with the assessment of trauma severity.

Where it's running

  • College of Medicine - Al-Nahrain University
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.